New Research Reports

Titan Company (TTAN) posted consolidated sales growth of 25% YoY in 1QFY26. Standalone jewelry sales (excl. bullion) rose 17% YoY, driven by an increase in ticket size (16% YoY) due to rising gold prices.

Cummins India (KKC) delivered robust performance in Q1FY26 which surpassed our estimates. Revenue, EBITDA and Adjusted PAT for the quarter was higher by 26%, 32% and 28% YoY on consolidated basis. The key positive of the management commentary was demand continuing to remain strong and also being broad based across key growth verticals such as Quick Commerce, Government led infra, manufacturing and pharma. KKC also clocked in healthy gross margin of 37% for the quarter. This is a result of the management's assiduous efforts in reducing direct material costs, optimizing product mix and...

During Jul-25, Indian steel prices declined 2% MoM to Rs49,700/tonne, while Chinese steel rose by 10% MoM to $490/tonne. Coking coal prices increased by 9% MoM to $148/tonne, driven by production cuts and a safety crackdown in China. In Jun-25, Indian steel production rose by 1% MoM to 13.7 mn tonnes. Estimated Chinese steel output declined by 4% MoM to 83 mn tonnes, while global steel production contracted by 4% MoM to 151 mn tonnes. Chinese steel exports fell by 8% MoM but rose 11% YoY to 9.6mn tonnes, amid growing speculation of production cuts by Chinese mills. Additionally, USA imposed steep tariffs on imports...

Prince Pipes' Q1FY26 result was below our estimates on key parameters. A major factor influencing the industry was the heightened volatility in PVC resin prices, which negatively impacted both volume growth and profitability across the sector. A sharp correction in these prices further resulted in inventory losses for the company in the trade channel, temporarily compressing margins in Q1FY26. The management has guided high single-digit to low double-digit volume growth for FY26E. EBITDA Margin is projected to improve going forward. Q2FY26 is expected to be better than Q1 on margin front, and the second half of...

VIP's Q1FY26 performance was below our expectations on all fronts. Revenue declined 12% YoY to Rs5.6bn, due to 8% YoY drop in volumes and 4% YoY decrease in NSR. This is due to sudden drop in secondary sales in E-com and intense price competition. Gross margin expanded by 69bps YoY to 45.0%. Despite this, EBITDA margins contracted 330bps YoY to 4.4%, dragged by inventory provision of Rs 150mn for slow moving SL. Adj. net loss stood at Rs150mn. Management refrained from articulating a forward strategy, citing the ongoing promoter-level exchange control situation as a limiting factor during this transition phase. We cut our FY26...

IRCON reported a subdued performance for Q1FY26, marked by a 21.9% YoY decline in consolidated revenue to Rs17bn and a 26.8% fall in net profit to Rs1.6bn. On a sequential basis, the revenue also contracted sharply by 47.7%, reflecting execution delays linked to project mobilization challenges and seasonal impact. Despite the steep revenue drop, the company delivered a robust EBITDA margin of 17.1%, improving 214 bps YoY and 695 bps QoQ. EPS for the quarter came in at Rs1.75, down from Rs2.38 in Q1FY25. While the decline in execution volume was expected due to monsoons and tendering...

Birlasoft reported a 1% QoQ revenue decline in Q1 to USD 150.7mn, driven by macroeconomic headwinds, client insourcing, and ramp-downs in manufacturing, while BFSI, Life Sciences & Services, and Energy & Utilities saw growth. EBITDA margin stood at 12.4%, impacted by the absence of Q4 one-offs. TCV wins reached USD 141mn, slightly lower due to seasonality and a deal shifting to Q2. Manufacturing and ERP remain under pressure amid tariff uncertainties, though medical devices show positive traction. ERP, despite challenges, remains a USD 200mn business. The company is focusing on mining its top 40 accounts,...

Kirloskar Oil Engines Ltd. (KOEL) posted healthy financial performance in Q1FY26. Power Gen (PG) segment clocked in 15% YoY growth to come in at Rs 6.1bn owing to sales volumes returning back to normalcy and healthy growth in the HHP segment. The LHP and MHP segment which is the mainstay of KOEL witnessed volumes normalizing back to the pre CPCB IV+ period. Demand trends stay positive with infrastructure verticals such as residential and commercial realty exhibiting good demand. Demand also continues to be broad based across various infrastructure verticals. The management wants to focus actively on...

We maintain a BUY rating on Fortis Healthcare with a target price of Rs 1,000/share.

We maintain a BUY rating with a 16% upside potential.